Expert guidance for second radiation treatments with curative aim
Part of Cancer clinical trials.
This trial studies whether using special computer software and expert input can safely give a second round of radiation to treat cancers that have come back or spread in a limited way. It aims to offer a chance for cure when standard treatments may not work.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have had radiation before in the same area that needs treatment again.
- Your cancer must be one of these types: a small number of tumors that have spread (oligo-metastases), only a few spots growing (oligo-progression), a new cancer that hasn't spread, or the original cancer coming back in the same spot.
- The re-irradiation must be intended to cure you (not just relieve symptoms), and you must have a life expectancy of more than 6 months.
- You cannot have re-irradiation planned for the brain, prostate, rectum, or esophagus.
- You must be able to pause certain cancer medications (like tyrosine kinase inhibitors) during treatment, if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a second round of precise, high-dose radiation (stereotactic body radiotherapy) for men whose prostate cancer has come back only in the prostate after their first radiation treatment. It aims to control the recurrence with fewer side effects.
This trial compares three treatment options for breast cancer that has come back in the chest or lymph nodes after previous radiation. It looks at adding hyperthermia (heating the tumor area) to re-irradiation, versus just re-irradiation or surgery alone, to see which offers better quality of life and survival with fewer side effects.
This study tracks patients receiving high-dose radiation therapy a second time (or more) to treat cancer that has come back or spread to a few spots. Researchers want to understand how well this approach works and what side effects patients experience.
This study tests whether giving a second course of radiation to the chest (called retreatment) can control lung cancer that has come back or a new cancer that started there. People who have already had radiation to their chest and are healthy enough for more may be eligible.
This trial tests giving a second course of radiation therapy to children and young adults with a type of brain tumor called diffuse midline glioma that has grown or come back after the first radiation. The goal is to see if re-irradiation can help control the tumor again.
This study tests a more personalized way to plan “re-irradiation,” meaning giving radiation again in an area that was already treated before. It aims to better calculate organ risk to reduce harmful side effects while treating cancer.
Hear when a new Radiotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.